摘要 |
<p>This invention relates to novel cyclic compounds which have the ability to modulate the activity of G protein-coupled receptors. The invention provides both agonists and antagonists. In preferred embodiments, the invention provides cyclic peptidic and cyclic or non-cyclic non-peptidic antagonists or agonists of C5a. The compounds of the invention are both potent and selective, and are useful in the treatment of conditions mediated by G protein-coupled receptors, especially conditions mediated by overexpression or underregulation of C5a, such as a variety of inflammatory conditions.</p> |